Retrospective Cohort Study
Copyright ©The Author(s) 2021.
World J Hepatol. Apr 27, 2021; 13(4): 456-471
Published online Apr 27, 2021. doi: 10.4254/wjh.v13.i4.456
Table 3 Subgroup analysis of patients who had endoscopic retrograde cholangiopancreatography on outcomes in elderly vs and non-elderly patients
Overall cohort, n = 292
PSM cohort, n = 142

Elderly, n = 206
Non-elderly, n = 86
OR, 95%CI
P value
Elderly, n = 77
Non-elderly, n = 65
OR, 95%CI
P value
Timing of ERCP from presentation0.012-0.247
Within 24 h15 (7.3)16 (18.6)9 (11.7)12 (18.5)
24-48 h36 (17.5)13 (15.1)14 (18.2)11 (16.9)
48-72 h34 (16.5)19 (22.1)12 (15.6)16 (24.6)
>72 h121 (58.7)38 (44.2)42 (54.6)26 (40)
Stone(s) removed102 (49.5)44 (51.2)0.94 (0.57, 1.55)0.79736 (46.8)30 (46.2)1.02 (0.53, 1.99)0.943
Stent placed89 (43.2)38 (44.2)0.96 (0.58, 1.60)0.87735 (45.5)30 (46.2)0.97 (0.50, 1.89)0.934
Length of hospital stay, d9 (7, 13)8 (5, 11)-0.0168 (5, 12)8 (5, 12)-0.546
In-hospital mortality2 (1)1 (1.2)0.83 (0.08, 9.31)0.8821 (1.3)1 (1.5)0.84 (0.05, 13.73)0.904
30-d mortality13 (6.3)4 (4.7)1.38 (0.44, 4.36)0.5813 (3.9)4 (6.2)0.62 (0.13, 2.87)0.536
90-d mortality16 (7.8)4 (4.7)1.73 (0.56, 5.32)0.3373 (3.9)4 (6.2)0.62 (0.13, 2.87)0.536